Searchable abstracts of presentations at key conferences in endocrinology

ea0063p6 | Adrenal and Neuroendocrine Tumours 1 | ECE2019

Adrenal insufficiency secondary to bilateral adrenal diffuse large B-cell lymphoma: a case report

Garcia Maria Laura , Speroni Romina , Lisdero Ana Paula

Introduction: Primary adrenal lymphoma is extremely rare. It accounts for <1% of extranodal lymphoma. It affects typically old males with bilateral adrenal gland involvement that leads to adrenal hypofunction. Prognosis is very poor due to the lack of optimum chemotherapeutic regimens.Case Report: A 71 yearr old man with prior history of non insulin dependent diabetes, was admitted to the emergency department with symptoms of progressive weakness, fa...

ea0070ep18 | Adrenal and Cardiovascular Endocrinology | ECE2020

Adrenal adenoma with hyperandrogenism and virilization in a postmenopausal women

Laura García María , Genovesi Elbio , Rella Noelia , Speroni Romina

Hyperandrogenism and virilization are infrecuent in postmenopausal women and may result from androgen-producing tumors. Androgen-secreting adrenal tumors are rare in clinical practice and often diagnosed as adrenocortical carcinoma, while benign androgen-secreting adrenal tumors are even more rare.Case presentation: A 63-year-old postmenopausal woman in follow-up for hypothyroidism reported hair loss, increased libido accompanied by deepening of the voic...

ea0070ep113 | Bone and Calcium | ECE2020

Zoledronic acid treatment in women with postmenopausal osteoporosis; A cohort follow–up.

García María Laura , Lisdero Ana Paula , Speroni Romina , Segarra Ana , Otero Jimena , Benito Camila , Giselle Mumbach Aizhar

Zoledronic acid (ZA) treatment increases bone mineral density (BMD), decreases bone turnover markers and reduces the risk of fractures in patients with osteoporosis (1).Objective: Observe and quantify the changes in BMD and bone turnover markers in postmenopausal osteoporosis (PO) patients treated annually with zoledronic acid 5 mg intravenously.Material and Methods: Medical records (MR) of PO patients whom received ZA from 2007 to...

ea0073pep15.5 | Presented ePosters 15: Late Breaking | ECE2021

Pheochromocytoma secreting IL-6; an atypical presentation

Laura García María , Lisdero Ana Paula , González Pernas Mariana , Speroni Romina , Segarra Ana , Otero Jimena , Genovesi Elbio , Belli Susana , Giselle Mumbach Aizhar

Pheochromocytoma (PCC) is a rare tumor that arises from the adrenal medulla, usually presents with headache, sweating and palpitations due to excessive catecholamine release. However, PCC may secrete neuropeptides, hormones and cytokines, such as interleukin-6 (IL-6)) resulting in unusual clinical manifestations. A 48-year-old woman with a previous history of type 1 neurofibromatosis (NF1) and hypertension was referred to discarded PCC. Laboratory tests revealed leukocytosis a...